Viatris Inc. | TalkMarkets

Latest Posts

The Terrible Ten

Video By: Paul Henneman

Friday, February 23, 2024 7:09 PM EDT

Most of the aforementioned group of quotable experts expect some mean reversion for the top stocks in the S&P 500 and counsel avoiding market cap weighting in favor of equal weighting.

In this video: RSP, SPLG, CF, IP, KEY, MPC, NUE, VLO, MCHP, STLD, SWKS, VTRS, SPX

Watch

These 3 Dividend Stocks Are Undervalued Using This Key Valuation Metric

Article By: SureDividend

Thursday, November 30, 2023 5:13 PM EDT

Book value is a valuable metric for discovering undervalued stocks. These 3 dividend payers are trading below book value.

In this article: KRC, SLG, VTRS

Read

Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal

Article By: ChinaBio® Today

Saturday, November 18, 2023 2:00 PM EDT

Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and commercialize the DLL3 group of cell therapies.

In this article: NVS, TBPH, LEGN, VTRS, APLM Also: WXXWY

Read

Daily Stock Analysis: Viatris

Article By: Fredrik Arnold

Thursday, July 20, 2023 7:52 PM EDT

Viatris Inc’s most recent $0.12 quarterly dividend, paid June 16th to shareholders of record May 23rd, equates to $0.48 annually to throw a yield of 4.58%.

In this article: VTRS

Read